Literature DB >> 31964276

Evaluation of Iodine Nutritional Status Among Pregnant Women in China.

Lichen Yang1, Min Li1, Xiaobing Liu1, Meng Wu2, Jian Zhang1, Liyun Zhao1, Gangqiang Ding1, Xiaoguang Yang1.   

Abstract

Background: Remarkable achievements have been made for over two decades by implementing a universal salt iodization policy in China. However, changes in the standards and manufacturing of iodized salt have made it necessary to regularly monitor iodine intake and thyroid function in the population. Therefore, we aimed to evaluate iodine nutritional status using thyroid function and urinary iodine levels in pregnant women via a national survey.
Methods: Participants included pregnant women enrolled in the 2015 Chinese Adults Chronic Diseases and Nutrition Surveillance (CACDNS). Urinary iodine concentration (UIC) was measured using arsenic and cerium catalysis spectrophotometry. Plasma levels of thyrotropin (TSH), fT4 (free thyroxine), thyroid peroxidase antibodies (TPO-Ab), and thyroglobulin antibodies (TG-Ab) were determined using an automated chemiluminescence immunoassay analyzer.
Results: UIC was analyzed in a total of 6173 urinary samples collected from pregnant women residing in 31 provinces of China. The median urinary iodine concentration was 146 μg/L. Pregnant women with UIC >250 μg/L had higher TSH levels than those with UIC 120-149 and 150-249 μg/L. After excluding women with positive TPO-Ab and TG-Ab, a total 2097 plasma samples collected from pregnant women during three periods were analyzed for TSH and fT4. The frequency of normal thyroid function in this study was >85%. The most common type of abnormal thyroid function, subclinical hypothyroidism, was similar to the 2010-2012 China Nutrition and Health Surveillance (CNHS), but its prevalence decreased to 6.8% compared with that in the 2010-2012 CNHS. Compared with pregnant women who had UIC <250 μg/L, the prevalence of subclinical hypothyroidism was significantly increased in those with UIC >250 μg/L. Even with UIC levels 120-149 μg/L, the iodine status of Chinese pregnant women in the 2015 CACDNS is acceptable. Conclusions: The iodine status of pregnant women is generally adequate, but urinary iodine levels are close to the cutoff for suitable iodine status (150 μg/L). With noniodized salt widely available, continued improvement in monitoring of iodine nutritional status and thyroid function is important in this population.

Entities:  

Keywords:  TSH; UIC; fT4; iodine; pregnant women; thyroid

Mesh:

Substances:

Year:  2020        PMID: 31964276     DOI: 10.1089/thy.2019.0001

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  4 in total

1.  Exploration of the optimal range of urinary iodine concentration in Chinese pregnant women in mildly iodine-deficient and -sufficient areas.

Authors:  Yanting Chen; Wenxing Guo; Ziyun Pan; Dingyan Zhang; Min Gao; Wen Wu; Chongdan Wang; Yifan Duan; Xuyang Gu; Elizabeth N Pearce; Jianqiang Lai; Wanqi Zhang
Journal:  Eur J Nutr       Date:  2021-11-05       Impact factor: 5.614

2.  Estimation of appropriate dietary intake of iodine among lactating women in China based on iodine loss in breast milk.

Authors:  Ying Zhang; Wenwen Gu; Xin Zhao; Le Shan; Zixuan Zhang; Xinhong Wu; Xinbao Zhang; Yanning Cao; Zhongna Sang
Journal:  Eur J Nutr       Date:  2022-10-08       Impact factor: 4.865

3.  Iodine Nutritional Status of Pregnant Women After 14 Years of Lipiodol Supplementation: a Cross-Sectional Study in Historically Iodine-Deficient Areas of China.

Authors:  Rishalaiti Tayier; Chenchen Wang; Pinjiang Ma; Yimu Yuan; Yuxia Zhang; Shunhua Wu; Ling Zhang
Journal:  Biol Trace Elem Res       Date:  2022-03-23       Impact factor: 3.738

4.  The relationship between different iodine sources and nutrition in pregnant women and adults.

Authors:  Rong Sun; Lijun Fan; Yang Du; Lanchun Liu; Tingting Qian; Meng Zhao; Wenjing Che; Peng Liu; Dianjun Sun
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-26       Impact factor: 6.055

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.